Login to Your Account



ExonHit Therapeutics' ALS Drug Fails In Phase III Trial

By James Etheridge


Wednesday, September 29, 2004
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription